Five-year outcomes of preoperative chemoradiation for rectal carcinoma in Saudi population: single-institutional experience

被引:1
作者
AlSaeed, Eyad Fawzi [1 ]
Tunio, Mutahir [2 ]
Zubaidi, Ahmad [3 ]
Al-Obaid, Omar [3 ]
Ahmed, Abdullah Kamal [4 ]
Al-Omar, Omar Abdulmohsen [4 ]
Abid, Emad Ahmed [4 ]
Alsiwat, Mohammed Jaber [4 ]
机构
[1] King Saud Univ, Dept Radiat Oncol, Riyadh, Saudi Arabia
[2] King Fahad Med City, Radiat Oncol, Riyadh, Saudi Arabia
[3] King Saud Univ, Dept Surg, Riyadh, Saudi Arabia
[4] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia
关键词
NEOADJUVANT THERAPY; COLORECTAL-CANCER; CHEMORADIOTHERAPY; MULTICENTER; RADIOTHERAPY;
D O I
10.5144/0256-4947.2015.23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Preoperative chemoradiation (CRT) followed by surgery is the standard treatment for locally advanced rectal cancer (LARC). The outcomes of preoperative CRT in Saudi patients with LARC have not been widely studied. The study reports long-term outcomes after preoperative CRT followed by curative surgery in Saudi patients with LARC. DESIGN AND SETTINGS: A retrospective, single-institutional study performed in the tertiary care oncology center in Saudi Arabia. MATERIALS AND METHODS: A total of 154 out of 204 patients with LARC were treated with preoperative CRT and followed by surgery at the oncology center between September 2005 and November 2012. Data regarding the response rates, toxicity profile, locoregional control (LRC), distant metastasis control (DMC), overall survival (OS), and disease-free survival (DFS) rates were analyzed. RESULTS: The median age of the study population was 56.6 years (range: 26-89). Predominant clinical stages were IIA (70 patients; 45.4%) and IIIB (49 patients; 31.8%). Majority of patients (79.8%) underwent a complete total mesorectal excision (TME). Complete pathological response (ypT0N0) was seen in 26 patients (16.8%). At 5 years, locoregional recurrence (LR) was reported in 12 patients (7.8%), and distant metastases were noted in 33 patients (21.4%). The 5-year cumulative LRC, DMC, OS, and DFS rates were 91%, 71.3%, 78%, and 64.8%, respectively. Stage, nodal status, circumferential margins, ypT0N0, and adjuvant chemotherapy were found to be important prognostic factors for DFS. CONCLUSION: The results of preoperative CRT followed by surgery and adjuvant chemotherapy in Saudi population are comparable with international data.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 27 条
[21]   Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial [J].
Tiva, M. ;
Puyraveau, M. ;
Mineur, L. ;
Calais, G. ;
Maingon, P. ;
Bardet, E. ;
Mercier, M. ;
Bosset, J. -F. .
CANCER RADIOTHERAPIE, 2010, 14 (6-7) :530-534
[22]   Can rectal cancers with pathologic to after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone? [J].
Tulchinsky, H ;
Rabau, M ;
Shacham-Shemueli, E ;
Goldman, G ;
Geva, R ;
Inbar, M ;
Klausner, JM ;
Figer, A .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (03) :347-352
[23]   Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial [J].
van Gijn, Willem ;
Marijnen, Carrie A. M. ;
Nagtegaal, Iris D. ;
Kranenbarg, Elma Meershoek-Klein ;
Putter, Hein ;
Wiggers, Theo ;
Rutten, Harm J. T. ;
Pahlman, Lars ;
Glimelius, Bengt ;
van de Velde, Cornelis J. H. .
LANCET ONCOLOGY, 2011, 12 (06) :575-582
[24]   Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: Long-term results of the German CAO/ARO/AIO-94 phase III trial [J].
Wolff, Hendrik Andreas ;
Conradi, Lena-Christin ;
Beissbarth, Tim ;
Leha, Andreas ;
Hohenberger, Werner ;
Merkel, Susanne ;
Fietkau, Rainer ;
Raab, Hans-Rudolf ;
Tschmelitsch, Joerg ;
Hess, Clemens Friedrich ;
Becker, Heinz ;
Wittekind, Christian ;
Sauer, Rolf ;
Roedel, Claus ;
Liersch, Torsten .
RADIOTHERAPY AND ONCOLOGY, 2013, 108 (01) :48-54
[25]   A Distribution Weighted Prognostic Scoring Model for Node Status in Advanced Rectal Cancer [J].
Yeo, Kwang-Hee ;
Kim, Ho Hyun ;
Kim, Dong-Yi ;
Kim, Young-Jin ;
Ju, Jae-Kyun .
CANCER RESEARCH AND TREATMENT, 2014, 46 (01) :41-47
[26]  
Zahrani AA, 2013, ANN ONCOL S4, V24, piv86, DOI [10. 1093/ annonc/ mdt203. 176, DOI 10.1093/ANNONC/MDT203.176]
[27]   Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study [J].
Zhu, Ji ;
Liu, Fangqi ;
Gu, Weilie ;
Lian, Peng ;
Sheng, Weiqi ;
Xu, Junyan ;
Cai, Gang ;
Shi, Debing ;
Cai, Sanjun ;
Zhang, Zhen .
RADIATION ONCOLOGY, 2014, 9